NCT02097992View on ClinicalTrials.gov

Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

COPD

Interventions

DRUG

Roflumilast Placebo

Placebo pill

DRUG

Roflumilast

500 Ug ORAL TABLET

Trial Locations (1)

33136

University of Miami Divison of Pulmonary and Critical Care Medicine, Miami

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

University of Miami

OTHER